Neuroblastoma Clinical Trials in Louisville, Kentucky

4 studies are recruiting for neuroblastoma in Louisville, Kentucky right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

    This phase III trial tests how well the addition of dinutuximab to Induction chemotherapy along with standard of care surgical resection of the primary tumor, radiation, stem cell transplantation, and immunotherapy works for treating children with newly diagnosed high-risk neuroblastoma. Dinutuxima…

    Stage
    Phase 3
    Ages
    Up to 30
    Site
    Norton Children's Hospital, Louisville, Kentucky
    Locations
    179 in total
    Run by
    National Cancer Institute (NCI)

    See if you can join NCT06172296 on ClinicalTrials.gov

  2. Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

    A prospective open label, multicenter study to evaluate the feasibility and acute toxicity of using molecularly guided therapy in combination with standard therapy followed by a Randomized Controlled Trial of standard immunotherapy with or without DFMO followed by DFMO maintenance for Newly Diagnos…

    Stage
    Phase 2
    Ages
    Up to 22
    Site
    Norton Children's Research Institute/Affiliated with University of Louisville School of Medicine, Louisville, Kentucky
    Locations
    28 in total
    Run by
    Giselle Sholler

    See if you can join NCT02559778 on ClinicalTrials.gov

  3. Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

    The purpose of this study is to evaluate the investigational drug, silmitasertib (a pill taken by mouth), in combination with FDA approved drugs for solid tumors. An investigational drug is one that has not been approved by the U.S. Food \& Drug Administration (FDA), or any other regulatory authori…

    Stage
    Phase 1
    Ages
    Up to 30
    Site
    Norton Children's Research Institute/Affiliated with University of Louisville School of Medicine, Louisville, Kentucky
    Locations
    23 in total
    Run by
    Milton S. Hershey Medical Center

    See if you can join NCT06541262 on ClinicalTrials.gov

  4. Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

    This is a prospective, multicenter clinical trial in subjects with newly diagnosed high-risk neuroblastoma to evaluate the efficacy and safety of administering naxitamab with standard induction therapy. The initial chemotherapy will include 5 cycles of multi-agent chemotherapy. Naxitamab will be ad…

    Stage
    Phase 2
    Ages
    1 to 21
    Site
    Norton Children's Research Institute/Affiliated with University of Louisville School of Medicine, Louisville, Kentucky
    Locations
    26 in total
    Run by
    Giselle Sholler

    See if you can join NCT05489887 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.